DiaSorin is an Italian multinational Group and a global leader in the market for in vitro diagnostics. For over 40 years the Group has been developing, producing and commercializing diagnostic tests for a wide range of clinical areas. DiaSorin tests are designed for hospital and private testing laboratories, in the markets of immunodiagnostics and molecular diagnostics. DiaSorin focused its business on improving the health and quality of people’s lives, through high-quality diagnostic products. The DiaSorin and Group’s activities business share a deep-rooted commitment to help people improve the quality of their lives, through the early detection of potential clinical diseases.